The Chinese University of Hong Kong
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1963-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.cuhk.edu.hk
Clinical Trials
1.4k
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (959 trials with phase data)• Click on a phase to view related trials
Utilizing Embodied Artificial Intelligence (AI) for the Development of Digital Cognitive Behavioral Therapy (CBT) for Depression in Virtual Reality (VR)
- Conditions
- Depression Scale Score
- First Posted Date
- 2025-09-15
- Last Posted Date
- 2025-09-15
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 60
- Registration Number
- NCT07172113
- Locations
- 🇭🇰
The Chinese University of Hong Kong, Hong Kong, Hong Kong
Quantitative Measurement of Plasma MTB Cell-free DNA Level
- Conditions
- Tuberculosis
- First Posted Date
- 2025-09-12
- Last Posted Date
- 2025-09-12
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 30
- Registration Number
- NCT07170735
- Locations
- 🇭🇰
Prince of Wales Hospital, Hong Kong, Hong Kong, Hong Kong
Musical Training to Enhance Resilience of Underprivileged School-aged Children
- Conditions
- ResilienceDepressive SymptomAnxiety
- First Posted Date
- 2025-09-10
- Last Posted Date
- 2025-09-10
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 174
- Registration Number
- NCT07165925
Post-operative Medium Chain Triglyceride Diet May Reduce Hospital Stay Following Lung Resection
- Conditions
- Thoracic Neoplasms
- First Posted Date
- 2025-09-08
- Last Posted Date
- 2025-09-08
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 210
- Registration Number
- NCT07159659
- Locations
- 🇭🇰
Prince of Wales Hospital, Shatin, Hong Kong
Transcranial Pulse Stimulation for Alzheimer's Disease
- Conditions
- Alzheimer Dementia (AD)
- First Posted Date
- 2025-08-27
- Last Posted Date
- 2025-09-05
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 40
- Registration Number
- NCT07143734
- Locations
- 🇭🇰
Department of Medicine & Therapeutics, Faculty of Medicine, The Chinese UNiversity of Hong Kong, Hong Kong, Hong Kong
- Prev
- 1
- 2
- 3
- 4
- 5
- 264
- Next
News
Immuno Cure Partners with PharmaJet to Advance HIV Therapeutic DNA Vaccine Using Needle-Free Delivery Technology
Immuno Cure and PharmaJet signed a collaboration agreement to evaluate the HIV therapeutic DNA vaccine ICVAX using PharmaJet's needle-free Tropis intradermal delivery system in clinical trials.
Cornerstone Robotics Secures $70M Series C to Challenge da Vinci's Surgical Robot Dominance
Cornerstone Robotics raised over $70 million in Series C funding led by EQT to accelerate commercialization of its Sentire endoscopic surgical system and challenge established players like da Vinci.
New Mainland Chinese Cancer Drug Shows Promising Results in Phase 1 Trial
A multinational study led by Chinese University of Hong Kong researchers found that D3S-001, a mainland-developed cancer drug, effectively treats tumors driven by KRAS-G12C gene mutations.
AI-Assisted Colonoscopy Boosts Adenoma Detection Rate by 40% in Junior Endoscopists
CU Medicine research demonstrates that AI-assisted colonoscopy significantly improves adenoma detection rates by 40% among junior endoscopists with less than three years of experience.
Microbiome Modulation with SIM01 Shows Promise for Long COVID Treatment in Randomized Trial
A randomized, triple-blind, placebo-controlled clinical trial by Chinese University of Hong Kong demonstrated that SIM01, an oral microencapsulated live bacteria formula, significantly improved long COVID symptoms compared to placebo.
D3Bio's Novel KRAS-G12C Inhibitor Shows Promising Results in Phase 1 Cancer Trial
A multinational study led by Chinese University researchers found that D3S-001, a mainland-developed KRAS-G12C inhibitor, demonstrated significant efficacy with over 70% of patients experiencing tumor shrinkage or disappearance.